New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 2, 2018 - Aquestive Therapeutics announced the FDA approval of Sympazan (clobazam) oral film, for the adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in patients 2 years of age or older.
Download PDF
Return to publications
